• Biopsy, Pericardial
  • Prostaglandin D2 (PGD2), Serum
  • Bacterial Vaginosis Pathogens by Molecular Method
  • Fluticasone 17-Beta-Carboxylic Acid, Urine
  • RET Proto Oncogene Mutation Analysis
  • Fructosamine (Glycated Protein)
  • Coccidioides By Molecular Method, CSF
  • B-Type Natriuretic Peptide (BNP) or Pro B-Type Natriuretic Peptide (Pro BNP)
  • Uric Acid, Serum
  • Nicotine and Metabolites, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /KRAS Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

KRAS Gene Mutation Analysis
Medical Test

Turnaround Time
Access to KRAS Gene Mutation Analysis is restricted.